Clinicore
NAD+ 500mg – Research Peptide Vial | CLINICORE Peptides
NAD+ 500mg – Research Peptide Vial | CLINICORE Peptides
Couldn't load pickup availability
NAD+ 500mg Research Peptide Vial
Lyophilised NAD+ supplied as a 500mg vial with defined analytical specifications for controlled laboratory research use.
CLINICORE NAD+ 500mg research peptide is supplied as a white to off white lyophilised powder in a single container format for laboratory and analytical workflows. This NAD+ peptide vial is intended for in vitro research environments where consistent presentation and documented specifications are required.
Overview
NAD+ is supplied by CLINICORE Peptides as a white to off white lyophilised powder in a single container format. This NAD+ research peptide listing is presented with clearly defined identity and quality markers to support laboratory documentation, reference preparation, and reproducible handling in research environments.
Handling and solubility
This section provides NAD+ handling and solubility information for laboratory workflows. Handle using appropriate laboratory PPE and standard laboratory safety procedures. Minimise exposure to ambient moisture and avoid unnecessary agitation during preparation.
NAD+ peptide powder is soluble in sterile water or bacteriostatic water for research use only. Reconstitute gently using controlled swirling to maintain solution integrity.
Storage guidelines
These NAD+ storage guidelines apply to lyophilised research peptides. Store in a cool, dry place away from light and keep the container tightly closed.
Intended use
This NAD+ research peptide is supplied strictly for laboratory research use only. It is not intended for human or veterinary use and is not approved for diagnostic, therapeutic, or medical applications. Use appropriate safety precautions.
CLINICORE quality and assurance
CLINICORE Peptides maintains a controlled, specification driven approach to research supply. Each NAD+ vial is presented with clearly defined identity and quality markers including stated content, appearance, and reported analytical purity to support consistent laboratory documentation and reproducible handling.
If additional documentation is required for internal QC or research records, please contact the CLINICORE team prior to use so we can advise what information may be available.
Share
